Supportive Oligonucleotide Therapy (SOT) targets specific genes within cancer cells, microorganisms, and viruses to inhibit their growth or survival. By utilizing small oligonucleotide molecules, SOT aims to disrupt key genetic signals responsible for promoting disease progression.